Dakota Wealth Management’s SAB Biotherapeutics SABS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,058
Closed -$510K 395
2021
Q3
$510K Hold
5,058
0.06% 222
2021
Q2
$504K Buy
+5,058
New +$504K 0.06% 220